Met-Enkephalin-Arg acetate salt H-Tyr-Gly-Gly-Phe-Met-Arg-OH acetate salt(CAS: 76310-14-0)

Met-Enkephalin-Arg acetate salt (CAS: 76310-14-0) falls under the GHS classification for hazardous substances. In the European Union, it falls under REACH regulations, which require manufacturers and importers to register substances with the European Chemicals Agency. Additionally, the FDA and EPA have specific requirements for the handling and transportation of pharmaceutical and chemical substances, including documentation and labeling standards.

Met-Enkephalin-Arg acetate salt (CAS: 76310-14-0) is often used in pharmaceutical and research applications. Alternatives in synthesis include other enkephalin analogs, such as Leu-enkephalin, and other peptides with similar structures. Common alternative reagents include various coupling agents and protecting groups, which can be substituted based on the specific requirements of the synthesis.

The market for Met-Enkephalin-Arg acetate salt (CAS: 76310-14-0) is driven by ongoing research in pain management and neuropharmacology. Recent trends indicate increased interest in peptide therapy and the development of new analgesics. Research is also focusing on the drug's potential in treating chronic pain and neuropathic pain conditions. Market trends suggest steady growth due to its established use in clinical trials and preclinical studies.

Waste containing Met-Enkephalin-Arg acetate salt (CAS: 76310-14-0) should be collected in appropriate containers and stored under controlled conditions to prevent degradation. Proper incineration or professional waste disposal methods should be used to ensure safe disposal. Environmental protection precautions include using personal protective equipment and following local regulations for hazardous waste management. It is crucial to maintain accurate records of waste handling and disposal.